SpringWorks Therapeutics logo
SpringWorks Therapeutics SWTX
$ 35.46 1.96%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

SpringWorks Therapeutics Income Statement 2011-2024 | SWTX

Annual Income Statement SpringWorks Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

3.26 B 1.7 B 2.74 B 3.73 B 448 M - - - - - - - -

Shares

63.1 M 53.3 M 48.5 M 43.3 M 13.3 M - - - - - - - -

Historical Prices

51.6 32 56.6 86 32 - - - - - - - -

Net Income

-325 M -277 M -174 M -45.6 M -58.3 M -17.8 M - - - - - - -

Revenue

5.45 M - -988 K 35 M - - - - - - - - -

Cost of Revenue

422 K - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-343 M -281 M -173 M -46.3 M -59.2 M -18.5 M - - - - - - -

Interest Expense

- - - 25 K - 678 K - - - - - - -

EBITDA

-341 M -280 M -173 M -46 M -59 M -18.5 M - - - - - - -

Operating Expenses

- - - 81.3 M 59.2 M - - - - - - - -

General and Administrative Expenses

198 M 135 M 71.8 M 29.5 M 16.7 M 8.59 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement SpringWorks Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

74.3 M 74.1 M 73.8 M 73.5 M 62.5 M 62.5 M 62.3 M 62.4 M 52.9 M 49.1 M 48.9 M 49.2 M 48.6 M 48.4 M 48.2 M 48.8 M 42.1 M 41.9 M 41.8 M 43 M 9.49 M 879 K 680 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-53.5 M -39.9 M -87.4 M - -79.4 M -77.9 M -73.4 M - -72.4 M -69 M -61.8 M - -41 M -47 M -29.8 M - -21.7 M -19.9 M -15.3 M -16.2 M -16.8 M -13.8 M -11.4 M -6.22 M -5 M -4.02 M -2.57 M -4.64 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

49.3 M 59.7 M 21 M - - - - - -1.49 M - -337 K - -267 K -159 K -261 K - -130 K -229 K -100 K - -2.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

3.34 M 2.45 M 1.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-57.9 M -44.9 M -93.9 M - -84 M -82.9 M -77.7 M - -71.7 M -69 M -61.5 M - -40.9 M -47 M -29.8 M - -21.6 M -19.8 M -16.1 M -17.4 M -15.3 M -14.9 M -11.7 M -6.45 M -5.23 M -4.22 M -2.59 M -4.66 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - -76 K -98 K -199 K - -74 K -24 K -193 K - -58 K -41 K 3 K - - - 936 K - 997 K - 279 K - 226 K - - 21 K - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -93.2 M - - - -77.4 M - -71.2 M -69 M -61.4 M - -40.6 M -47 M -29.6 M - -21.4 M -19.7 M -16.1 M -17.4 M -15.2 M -14.8 M -11.7 M -6.45 M -5.22 M -4.22 M -2.59 M -4.66 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - 84 M 82.9 M 77.7 M - 71.7 M 69 M 61.5 M - 40.9 M 47 M 29.8 M - 21.6 M 19.8 M 16.1 M - 15.3 M 14.9 M 11.7 M - 5.23 M - - 4.66 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

61.6 M 57.8 M 60.1 M - 46.5 M 47 M 44.2 M - 35.7 M 31 M 27.4 M - 18 M 14.9 M 12.4 M - 7.67 M 6.87 M 6.4 M - 4.58 M 3.65 M 3.26 M - 1.82 M - - 1.86 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency